PRINCETON, N.J., February 25, 2019 – Taiho Oncology, Inc. today
CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics,
FDA warns 17 companies about illegal Alzheimer disease products
(HealthDay)—A number of warning/advisory letters have been issued to 17
Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced
Juul – the most controversial E-cigarette in the world comes to Germany
There are only a few products on the market that
FDA Approves Aemcolo
November 16, 2018 — The U.S. Food and Drug Administration
FDA proposes ban on menthol cigarettes, new restrictions on flavored e-cigs
In a landmark move, the U.S. Food and Drug Administration
FDA approves pill for hot flashes in menopausal women
TherapeuticsMD announced Monday that its single-pill hormone therapy for menopausal
FDA Approves Talzenna
On October 16, 2018, the Food and Drug Administration approved
FDA Approves Arikayce To Treat Bacterial MAC Lung Disease
Arikayce is used to treat a rare condition called MAC